Browsing: General Catalyst
Conntour Raises $7M From General Catalyst, YC To Build AI Search Engine For Security Video Systems
The surveillance technology industry is in the spotlight today, but not for the best of reasons. With controversy surrounding US Immigration and Customs Enforcement tapping into…
Miragethe maker of video editing app Captions, has raised $75 million in growth funding from General Catalyst’s Customer Value Fund (CVF). Over the past year, the…
Consumer-focused privacy firm Cloaked raises $375 million as it expands into the enterprise
Consumer-facing security tools often focus on one type of approach, such as password protection, VPN, or identity management. This forces people to use many tools to…
Roxa startup that develops autonomous artificial intelligence agents to boost sales productivity has raised a new round of funding that values the company at $1.2 billion,…
based in Bengaluru Quicklyis helping to bring India’s largely informal domestic aid market online. As daily bookings increase and the city’s footprint expands, investors are opening…
General Catalyst, a Silicon Valley-based venture capital firm with more than $43 billion in assets under management, has announced plans to invest $5 billion in India…
One of the most important decisions early-stage founders have to make is who to bring in as a founding team. The first five to ten employees…
AI inference startup Modal Labs is in talks to raise valuation to $2.5 billion, sources say
Modal Labsa startup that specializes in artificial intelligence inference infrastructure is talking to VCs about a new round at a valuation of about $2.5 billion, according…
Bolna Captures $6.3M From General Catalyst For India-Focused Voice Orchestration Platform
Industry exhibitions and its development voice modeling companies in the Indian market suggest that there is a growing demand for voice AI solutions in the country.…
From OpenAI offices to Eli Lilly deal – how Chai Discovery became one of the most impressive names in AI drug development
Drug discovery, the art of identifying new molecules for drug development, is a notoriously time-consuming and difficult process. Traditional techniques such as high performance controlthey offer…